Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

Clinical trial NCT06854107 · COMPLETED

Trial details

NCT number: NCT06854107
Sponsor: Zilong Yuan
Status: COMPLETED
Study type: OBSERVATIONAL

Pathologic Complete Response

Start date: 2023-12-01
Primary completion: 2023-12-01
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.